<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> are frequently treated with radiofrequency ablation (RFA) </plain></SENT>
<SENT sid="1" pm="."><plain>Those that undergo this procedure have a low risk of developing subsquamous <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath>, and none have been reported to develop subsquamous <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We report the development of subsquamous <z:hpo ids='HP_0002664'>neoplasia</z:hpo> in 3 patients who were treated with RFA for <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (2 developed <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and 1 developed high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>) </plain></SENT>
<SENT sid="3" pm="."><plain>The identification of these cases indicates the need for continued surveillance following RFA, even after complete eradication of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath>, and caution for widespread use of ablation, especially in patients with low-risk <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
</text></document>